Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on July 30, 2026

Jul. 30, 2026

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Indeterminate GlobeNewswire

Jul. 30, 2026

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 30, 2026

SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts

Indeterminate GlobeNewswire

Jul. 30, 2026

DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq

Indeterminate GlobeNewswire

Jul. 30, 2026

DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq

Indeterminate GlobeNewswire

Jul. 30, 2026

Medical Oncology Software Market to Reach US$ 7.5 Billion by 2033 at 6.6% CAGR | Persistence Market Research

Indeterminate EIN Presswire

Jul. 30, 2026

Women's Health Diagnostics Market to Reach US$ 47.1 Billion at 5.9% CAGR by 2033 | Persistence Market Research

Indeterminate EIN Presswire

Jul. 30, 2026

Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.

Indeterminate GlobeNewswire

Jul. 30, 2026

FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Cellectis to Report Second Quarter Financial Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

STERIS Raises Dividend to $0.69 per share

Indeterminate GlobeNewswire

Jul. 30, 2026

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire

Jul. 30, 2026

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

Indeterminate GlobeNewswire

Jul. 30, 2026

CooperCompanies Announces Release Date for Third Quarter 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound

Indeterminate GlobeNewswire

Jul. 30, 2026

Red Sift launches new email defense integrations for Claude and ChatGPT

Indeterminate EIN Presswire

Jul. 30, 2026

GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology

Indeterminate GlobeNewswire

Jul. 30, 2026

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

Indeterminate GlobeNewswire

Jul. 30, 2026

Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod

Indeterminate GlobeNewswire